Records containing: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-04-06
  Prospective Single Arm Observational Cohort Study of Ultrasound Guided Intra Ovarian Injection of Muse Cells (Multilineage Differentiating Stress-Enduring Cells) for Reversal of Perimenopausal Ovarian Decline in Women Aged 28-70 Years
• CLINICAL_TRIALS study record update · 2026-03-09
  Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)
• CLINICAL_TRIALS study record update · 2025-07-14
  Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Elinzanetant in Participants With Impaired Renal Function in Comparison to Matched Controls With Normal Renal Function
• CLINICAL_TRIALS study record update · 2024-05-08
  A Randomized, Double-blind, Placebo- and Active-controlled, 4-period, Crossover Study to Investigate Effects of Elinzanetant on Simulated Driving Performance and Cognitive Function in Healthy Women
• CLINICAL_TRIALS study record update · 2023-08-09
  Single Center, Randomized, Open-label, Cross-over Study to Investigate the Pharmacokinetics of Two Oral Formulations of Elinzanetant After Single Dosing in Healthy Participants
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2023-08-09
  Open-label, One-sequence Crossover Study to Determine the Effects of Multiple Doses of Elinzanetant on the Pharmacokinetics of Rosuvastatin in Healthy Participants
• CLINICAL_TRIALS study record update · 2023-05-09
  A Randomized, Double-blind, Placebo- and Moxifloxacin-controlled Study to Investigate the Safety and Pharmacokinetics of Single Ascending Supratherapeutic Doses of Elinzanetant in Healthy Participants
• CLINICAL_TRIALS study record update · 2022-11-22
  Open-label, Fixed Sequence Crossover Study to Determine the Effects of a Single Dose of Elinzanetant (BAY 3427080) on the Pharmacokinetics of Dabigatran Etexilate in Healthy Participants
• CLINICAL_TRIALS study record update · 2022-07-27
  A Randomized, Single-blind, Placebo-controlled Study to Investigate the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of Elinzanetant in Chinese Healthy Female Participants 40 to 65 Years of Age
• CLINICAL_TRIALS study record update · 2022-07-19
  A Combined Single- and Multiple-dose, Open-label, Randomized, 2 x 2 Crossover Study to Investigate the Relative Bioavailability, the Safety and the Tolerability of Elinzanetant (BAY 3427080) in Healthy Female and Male Participants
• CLINICAL_TRIALS study record update · 2022-03-29
  A Randomized, Placebo-controlled, Single-blind, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics After Single and Multiple Dose of Elinzanetant in Japanese Healthy Female Adult Participants
• CLINICAL_TRIALS study record update · 2022-03-24
  Open-label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Elinzanetant in Participants With Impaired Hepatic Function (Classified as Child-Pugh A or B) in Comparison to Matched Controls With Normal Hepatic Function.
• CLINICAL_TRIALS study record update · 2022-03-17
  An Open-label, Non-randomized,Fixed-sequence Crossover Study to Investigate the Effects of a Proton Pump Inhibitor on the Pharmacokinetics of Elinzanetant (BAY 3427080) as Well as Assessment of the Absolute Bioavailability of Elinzanetant Using a Single Intravenous Microtracer Dose of [13C5]BAY 3427080 in Male and Female Healthy Participants
• CLINICAL_TRIALS study record update · 2022-02-25
  Open-label, Fixed Sequence Crossover Study to Investigate the Effects of Carbamazepine on the Pharmacokinetics of Elinzanetant (BAY 3427080) in Healthy Participants.